SCHEMBL6685253

SCHEMBL6685253

Cc1ccc(Nc2ccc(C(=O)c3ccccc3C)c(Cl)c2)c([N+](=O)[O-])c1

nearest known ligand 0.82

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 12/20 0.82
MAPK13 O15264 11/20 0.82
MAPK12 P53778 11/20 0.82
MAPK11 Q15759 11/20 0.82
KCNMA1 Q12791 2/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
LMNA P02545 2/20 0.47
NPC1 O15118 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C19 P33261 1/20 0.47
RAB9A P51151 1/20 0.47
ALDH1A1 P00352 1/20 0.46
ATM Q13315 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6655015 0.90 MAPK14 (1.00) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL7196766 0.90 MAPK14 (0.79) MAPK14MAPK13MAPK12MAPK11KCNMA1
SCHEMBL7198829 0.90 MAPK14 (0.79) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL7193764 0.88 MAPK13 (0.76) MAPK14MAPK13MAPK12MAPK11NPC1
SCHEMBL7196663 0.87 MAPK13 (0.74) MAPK14MAPK13MAPK12MAPK11KCNMA1
SCHEMBL7196772 0.85 MAPK14 (0.82) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL7210815 0.85 MAPK13 (0.62) MAPK14MAPK13MAPK12MAPK11KCNMA1
SCHEMBL7198680 0.83 MAPK13 (0.78) MAPK14MAPK13MAPK12MAPK11KCNMA1
SCHEMBL6655830 0.82 MAPK14 (0.80) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL7207479 0.82 MAPK13 (0.76) MAPK14MAPK13MAPK12MAPK11LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0966424-B1 AMINOBENZOPHENONES AS INHIBITORS OF INTERLEUKIN AND TNF LEO PHARMA AS (DK) 2004-06-23 EP disclosed
US-6313174-B1 FOR THERAPY AND PROPHYLAXIS OF ASTHMA, ALLERGY, RHEUMATOID ARTHRITIS, SPONDYLOARTHRITIS, GOUT, ATHEROSCLEROSIS, CHRONIC INFLAMMATORY BOWEL DISEASE, PROLIFERATIVE AND INFLAMMATORY SKIN DISORDERS Leo Pharmaceutical Products Ltd.A/S/ (Løvens kemiske Fabrik Produktionsaktieselskab) (DK) 2001-11-06 US disclosed